Skip to content
HOME discovery services screening endothelial barrier function

Endothelial barrier function


The endothelium of vessels is responsible for vascular tone and permeability and its function is disturbed in diseases like atherosclerosis, diabetes or hypertension. Impedance-based assays measure the obstruction to alternating current flow to monitor the morphology, viability and permeability of the endothelial barrier. Our experts use Ncardia’s human iPSC-derived endothelial cells to model endothelial barrier in vitro and perform impedance assays to provide an analysis of acute and chronic compound effects on vascular barrier function.

Assay
Benefits
  • Non-invasive technology
  • Multiplexing options
  • Sensitive for short and long-term assessments
contact

Do you want to explore how this assay can help you progress your drug discovery programs? Contact our expert

Applications

Early screening of endothelial barrier permeability allows establishment of drug dose-limits to avoid adverse effects of therapeutic candidates. Impedance assay can monitor time course changes in endothelial permeability, cell matrix interaction and cell membrane capacitance with high sensitivity. Our advance data analysis capabilities enable discrimination between necrosis and apoptosis, subtle loss of cell-cell contacts or acute cell death.

Barrier resistance

Assessment of endothelial barrier resistance and permeability in 3 batches of human iPSC-derived endothelial cells.

Endothelial barrier resistance increases as the monolayer is established in the plate and remains stable long-term. Compounds can be added at the desired time point to study the effect on endothelial barrier function and permeability.

The figure shows barrier resistance measured at 4 kHz over time using ECISTM (Applied Biophysics) in 3 different batches. It shows reproducibility between batches.
Resources
Related assays
Questions about our assays?

Our work centers on a simple yet powerful premise: 
When we combine deep iPSC knowledge, broad assay capabilities and a demonstrated ability to integrate the biology of human diseases into preclinical research, we can help drug developers make critical decisions earlier and with more confidence.